Portfolio company
Holostem Srl
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops and manufactures advanced therapy medicinal products based on epithelial stem cell cultures for patients with rare ocular and skin diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Aurealis Pharma
This company develops cell and gene therapies for patients suffering from chronic wounds, cancer and inflammatory diseases.
StemSight
This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.
CynosBio
This company develops regenerative medicine products, including autologous cell therapies for ophthalmology and orthopaedics, serving healthcare professionals and patients with severe unmet medical needs.
Castle Creek Biosciences
This company develops cell and gene therapies for patients suffering from rare genetic skin and connective tissue diseases.
AddGraft Therapeutics
This company develops genetically engineered liquid skin grafts for patients with rare skin diseases and metabolic disorders.
Eyestem
The company develops cell replacement therapies to treat incurable blindness and retinal diseases for patients globally.
Luminary Therapeutics
This biotechnology company develops cell therapies to treat patients with cancers and autoimmune diseases.
Promethera
The company develops stem cell therapies to treat severe liver diseases for patients suffering from acute-on-chronic liver failure and other end-stage liver conditions.
